Franklin Biotechnology Discovery Fund closed to all new investors at close of market on July 8, 2014. Existing investors may continue to purchase additional shares of the fund. For more information, please contact your financial advisor or call Franklin Templeton Shareholder Services at (800) 632-2301.
|CUSIP||354 713 844|
|Inception Date||Sep 15, 1997|
|Total Net Assets (all share classes) As of 01/31/2016||$1,235.6 (M)|
|Distribution Rate at NAV||N/A|
|30-Day Standardized yield||N/A|
|Gross Expense Ratio||
|Net Expense Ratio||
|Max Initial Sales Charge||
The fund seeks capital appreciation by investing at least 80% of its net assets in securities of biotechnology companies and discovery research firms including those involved in fields such as genomics, genetic engineering, and gene therapy, as well as health care, pharmaceuticals and agriculture.
You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.